Publications by authors named "Kai Prager"

Claim this Profile
E
Evaluation of an enzymatic one-step assay for Beta-Hydroxybutyrate blood testing on clinical chemistry platforms using HILIC-MS/MS as a non-enzymatic reference method.
Max K Steinbach, Holger Müller, Yanik Reichard, Konstantin Eulberg, Tobias Frömel, Kai Prager

Clin Chim Acta· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards routine high-throughput analysis of fecal bile acids: validation of an enzymatic cycling method for the quantification of total bile acids in human stool samples on fully automated clinical chemistry analyzers.
Angelique Masetto, Tina Leber, Tobias Frömel, Christoph Peter, Kai Prager

Clin Chem Lab Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.
Johannes Levin, Nand Sing, Sue Melbourne, Amber Morgan, Carla Mariner, Kai Prager

EBioMedicine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel trends in celiac disease.
Torsten Matthias, Sandra Neidhöfer, Sascha Pfeiffer, Kai Prager, Sandra Reuter

Cell Mol Immunol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
Marit Stirnberg, Eva Maurer, Angelika Horstmeyer, Sonja Kolp, Stefan Frank, Kai Prager

Biochem J· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis.
Irfan Y Tamboli, Kai Prager, Dietmar R Thal, Karin M Thelen, Ilse Dewachter

J Neurosci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural switch of presenilin 1 by glycogen synthase kinase 3beta-mediated phosphorylation regulates the interaction with beta-catenin and its nuclear signaling.
Kai Prager, Lihua Wang-Eckhardt, Regina Fluhrer, Richard Killick, Esther Barth

J Biol Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of endogenous amyloid precursor protein processing due to cellular aging.
Andreas Kern, Birgit Roempp, Kai Prager, Jochen Walter, Christian Behl

J Biol Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network.
Tina Wahle, Kai Prager, Nikolai Raffler, Christian Haass, Michael Famulok

Mol Cell Neurosci· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide.
Irfan Y Tamboli, Kai Prager, Esther Barth, Michael Heneka, Konrad Sandhoff

J Biol Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11.
Alejandro Brun, Joaquín Castilla, Miguel A Ramírez, Kai Prager, Beatriz Parra

Neurosci Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis